- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05808478
Eye-tracking Technology for Severe Communication Disability
Augmentative Alternative Communication Intervention Delivered Via Eye-tracking Technology
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The term "complex communication needs" includes all patients who present severe disturbances in speech and language production and/or in comprehension, in relation to oral or written communication modalities. The main purpose of Augmentative and Alternative Communication (AAC) is to promote the best possible communication for people with complex communication needs, through the use of techniques, methods and tools aimed not at replacing pre-existing communication methods but at increasing skills of natural communication through the enhancement of present skills. The Eye tracker system, thanks to allows the recording and analysis of eye movements, could be used successfully to support communication in patients with severe communication disability.
The goal of this study is to develop an efficacy Augmentative and Alternative Communication intervention using eye-tracking technology for patients with severe communication disability.
The secondary objective was to examine the psychosocial impact of technology for AAC on parents' perspectives and quality of life.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Francesca Cuinotta, MD, PhD
- Phone Number: 09060128257
- Email: francesca.cucinotta@irccsme.it
Study Locations
-
-
-
Messina, Italy, 98100
- Recruiting
- IRCCS Neurolesi Bonino Pulejo
-
Contact:
- Francesca Cucinotta, PhD
- Phone Number: 09060128256
- Email: francesca.cucinotta@irccsme.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- aged between 3 and 17 years affected by neuropsychiatric pathology presenting complex communication needs
- Control of eye motility and visual fixation
- ability to maintain position in front of the monitor
- availability of at least one member of the family nucleus to participate in the therapeutic process
- cognitive skills appropriate to the task such as being able to recognize images and being able to memorize procedures necessary to use the various basic functions
Exclusion Criteria:
- age not between 3 and 17 years
- difficulty in controlling ocular motility and visual fixation
- the unavailability of at least one member of the family nucleus to participate in the therapeutic process
- impaired cognitive skills on the task such as being able to recognize pictures and being able to memorize procedures necessary to use various basic functions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental Group (EG)
The experimental group will undergo treatment with innovative high-tech tools, such as Eye Tracking, for communication purposes.
The duration of the treatment will be six months, twice a week, with sessions of 45 minutes.
|
The AAC treatment will be supported by the use of an innovative high-tech tool, such as Eye Tracking.
The duration of treatment will be 6 months, with sessions of 45 minutes twice a week.
|
|
Active Comparator: Control Group (CG)
The control group will undergo conventional AAC treatment, with low-tech tools, such as PECS or sign language. The duration of the treatment will be six months, twice a week, with sessions of 45 minutes. |
Treatment involves the use of conventional AAC, with low-tech tools, such as PECS or sign language.
The duration of treatment will be six months, twice a week, with sessions of 45 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MacArthur-Bates Communicative Development Inventory
Time Frame: Month 0
|
The MacArthur-Bates Communicative Development Inventory is a questionnaire for parents.
This is used for the study and evaluation of communication and language in children with typical and atypical development.
|
Month 0
|
|
MacArthur-Bates Communicative Development Inventory
Time Frame: Month 3
|
The MacArthur-Bates Communicative Development Inventory is a questionnaire for parents.
This is used for the study and evaluation of communication and language in children with typical and atypical development.
|
Month 3
|
|
MacArthur-Bates Communicative Development Inventory
Time Frame: Month 6
|
The MacArthur-Bates Communicative Development Inventory is a questionnaire for parents.
This is used for the study and evaluation of communication and language in children with typical and atypical development.
|
Month 6
|
|
Communication Matrix
Time Frame: Month 0
|
is an online assessment tool created to help professionals and family members support people with severe communication disorders on their journey to greater self-expression.
Total score on an assessment of early expressive communication skills.
|
Month 0
|
|
Communication Matrix
Time Frame: Month 3
|
is an online assessment tool created to help professionals and family members support people with severe communication disorders on their journey to greater self-expression.
Total score on an assessment of early expressive communication skills.
|
Month 3
|
|
Communication Matrix
Time Frame: Month 6
|
is an online assessment tool created to help professionals and family members support people with severe communication disorders on their journey to greater self-expression.
Total score on an assessment of early expressive communication skills.
|
Month 6
|
|
Interactive Check list for Augmentative Communication
Time Frame: Month 0
|
Interactive Check list for Augmentative Communication is an observational tool for evaluating interactive behavior
|
Month 0
|
|
Interactive Check list for Augmentative Communication
Time Frame: Month 3
|
Interactive Check list for Augmentative Communication is an observational tool for evaluating interactive behavior
|
Month 3
|
|
Interactive Check list for Augmentative Communication
Time Frame: Month 6
|
Interactive Check list for Augmentative Communication is an observational tool for evaluating interactive behavior
|
Month 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The World Health Organization Quality of Life
Time Frame: T0 (Baseline) - T1 (3 months) - T2 (6 months)
|
The World Health Organization Quality of Life -BREF consists of 26 questions.
The World Health Organization Quality of Life -BREF has Likert-type scoring ranging from 1 to 5. As the score obtained from the sub-domains of the scale increases, the quality of life increases.
|
T0 (Baseline) - T1 (3 months) - T2 (6 months)
|
|
Parenting Stress Index
Time Frame: T0 (Baseline) - T1 (3 months) - T2 (6 months)
|
Measures parenting stress
|
T0 (Baseline) - T1 (3 months) - T2 (6 months)
|
|
Forerunners in Communication - ComFor
Time Frame: T0 (Baseline) - T1 (3 months) - T2 (6 months)
|
Forerunners in Communication assesses the precursors of augmentative communication.
It measures the ability to perceive and attribute meanings to forms of communication
|
T0 (Baseline) - T1 (3 months) - T2 (6 months)
|
|
Vineland Adaptive Behavior Scales II
Time Frame: T0 (Baseline) - T1 (3 months) - T2 (6 months)
|
The Vineland Adaptive Behavior Scales are a standardized semi-structured interview to measure adaptive behavior, among the most sensitive to change in autism research.
Standard scores have a mean of 100 and a standard deviation of 15.
|
T0 (Baseline) - T1 (3 months) - T2 (6 months)
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Mirenda P, Eicher D, Beukelman DR. Synthetic and natural speech preferences of male and female listeners in four age groups. J Speech Hear Res. 1989 Mar;32(1):175-83. doi: 10.1044/jshr.3201.175. Erratum In: J Speech Hear Res 1989 Sep;32(3):703.
- Corallo F, Bonanno L, Lo Buono V, De Salvo S, Rifici C, Pollicino P, Allone C, Palmeri R, Todaro A, Alagna A, Bramanti A, Bramanti P, Marino S. Augmentative and Alternative Communication Effects on Quality of Life in Patients with Locked-in Syndrome and Their Caregivers. J Stroke Cerebrovasc Dis. 2017 Sep;26(9):1929-1933. doi: 10.1016/j.jstrokecerebrovasdis.2017.06.026. Epub 2017 Jul 18.
- Uliano D, Falciglia G, Del Viscio C, Picelli A, Gandolfi M, Passarella A. Augmentative and alternative communication in adolescents with severe intellectual disability: a clinical experience. Eur J Phys Rehabil Med. 2010 Jun;46(2):147-52. Epub 2010 Apr 13.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EYETRACK01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Communication Disabilities
-
Joel E. RingdahlEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingIntellectual Disability | Self-Injurious Behavior | Autism Spectrum Disorder | Communication Disabilities | Communication, NonverbalUnited States
-
Hamad Medical CorporationNot yet recruiting
-
IRCCS Fondazione Stella MarisFondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione I.R... and other collaboratorsRecruitingNeurodevelopmental Cognitive, Motor and Speech-language DisabilitiesItaly
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; New...CompletedCritical Illness | Communication DisabilitiesUnited States
-
University of Colorado, DenverPatient-Centered Outcomes Research Institute; Mayo Clinic; University of Michigan and other collaboratorsCompletedCommunication DisabilitiesUnited States
-
Northwestern UniversityPatient-Centered Outcomes Research InstituteRecruitingDevelopmental DelaysUnited States
-
Centre Hospitalier Intercommunal CreteilAssociation pour la recherche des troubles de l'apprentissage; Orthoédition; Association... and other collaboratorsCompletedDevelopmental Disability | Learning Disorders, SpecificFrance, Martinique
-
Boin ChoiRecruitingAutism Spectrum Disorder | Developmental Disabilities | Developmental Delay | Teacher Training | Inclusive EducationSouth Korea
-
Beacon Hill AcademyAnglia Ruskin University; The Music Therapy Charity LtdWithdrawnChild Development Disorders, Specific | Developmental Communication DisordersUnited Kingdom
-
Bartın UnıversityNot yet recruitingLearning DisabilitiesTurkey (Türkiye)
Clinical Trials on AAC + Eye Tracking
-
University of AlbertaCompleted
-
McGill UniversityInnodem NeurosciencesRecruitingClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisCanada
-
Instituto Universitario de Oftalmobiología Aplicada...Hospital del Rio Hortega; Hospital Clínico Universitario de ValladolidCompletedMultiple Sclerosis | Eye Abnormalities | Parkinson Disease | Ataxia, Cerebellar | Injury BrainSpain
-
Innodem NeurosciencesRecruitingAlzheimer's DiseaseCanada
-
Central South UniversityUnknownBipolar Disorder | Suicide | Major Depressive DisorderChina
-
University Hospital, AngersUnknownHuntington DiseaseFrance
-
Institut National de la Santé Et de la Recherche...CompletedHealthy | Parkinson Disease | DystoniaFrance
-
Innodem NeurosciencesNovartis PharmaceuticalsRecruitingMultiple SclerosisCanada
-
Innodem NeurosciencesSyneos HealthCompleted
-
Radboud University Medical CenterLund University; Utrecht UniversityCompleted